Objectives: As the most common sustained cardiac arrhythmia, atrial fibrillation (AF) is regarded as a heritable disease partially. Most former researches were concentrated in heterozygous mutations or single nucleotide polymorphisms (SNPs) in the exon coding regions. The relationship between AF occurrence and SNPs in nonproteincoding micro-RNAs is still mysterious. Our study focused on this filed. Methods: A total of 123 participants were enrolled from genetically unrelated ethnic Han Chinese living in Nantong city of Jiangsu Province. 65 atrial fibrillation patients (Male: 53.85%; Age: 69.75AE13.44) were confirmed with electrocardiogram or Holter, 58 normal individuals (Male: 48.28%; Age: 63.36AE14.11) were assigned to control group. Genotypes of the pre-miRNA SNP rs11614913 in miR-196a2 were distinguished using the method of polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) assay. The primers used for amplification were 5'-TCCA GATAGATGCAAAGCTGAA-3' (forward) and 5'-ATAGGTTGAGAGGACGGCA TAA-3' (reverse). PCR products were digested by specific restriction enzyme Hpy188I, and then separated by 2% agarose gel electrophoresis. For hsa-mir-196a2 rs11614913 C/T, allele T is cuttable, yielding two fragments of 81 bp and 219 bp, allele C is uncuttable and the fragment is still 300 bp. Hardy-Weinberg equilibrium were evaluated by chi-square test. Student's t test for continuous variables and chi-square test for categorical variables were used. Odds ratio (OR) and 95% confidence intervals (CI) were reported to estimate the associations between genotypes and AF risk using logistic regression analyses. Differences were considered statistically significant at P<0.05. Results: The genotype frequencies were 15.4% (TT), 46.1% (TC), and 38.5% (CC) for the AF patients, while 39.7% (TT), 46.5% (TC), and 13.8% (CC) for the control participants. Significantly increased AF risk was found to be associated with C allele (P<0.0001; OR, 2.716; 95% CI, 1.620-4.553). Compared with miR-196a2 rs11614913 wild-type homozygote TT, significantly increased AF risks exist in variant homozygote CC (OR, 8.625; 95% CI, 2.939-25.316) and heterozygote TC (OR, 2.556; 95% CI, 1.032-6.326). After Adjusting for age and sex, participants with TC/CC genotypes still show high risk for AF statistically (OR, 3.614; 95% CI, 1.537-8.497).
oxidative injury model. The level of PAPP-A mRNA and protein were evaluated by RT-PCR and Western Blotting. Then we observed the change in PAPP-A mRNA and protein expression after treatment with atorvastatin. Results: Compared with control group, PAPP-A mRNA and protein levels increased in a dose and time-dependent manner when VSMCs were induced by ox-LDL. After exposure to ox-LDL (300 mg/ml) for 12 and 24h, PAPP-A mRNA and protein levels were dramatically increased (P<0.01). However, PAPP-A mRNA and protein levels were strongly decreased after atorvastatin treatment. Conclusions: Atorvastatin can regulate the expression of PAPP-A mRNA and protein induced by ox-LDL, which demonstrate that PAPP-A is probably involved in the anti-As mechanism of atorvastatin.
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Toll Objectives: Toll-like receptor 4 participates in the process of acute heart injury. The underlying mechanisms of its protection are multi-factorial, but we hypothesized that Toll-like receptor-mediated autophagy control plays a vital role. The purpose of this study was to clarify the effect of autophagy on cardiac fibrosis. Methods: Cardiac fibrosis was induced by subcutaneous isoproterenol (ISO) injection, and rapamycin was simultaneously administered orally for 14 days. Animal echocardiography was then used to evaluate the success of the cardiac fibrosis model, and the mice were sacrificed after the echocardiography examination. Results: Toll-like receptor-4 knockout (TLR4 KO) mice had better heart function than did wild-type (WT) mice (P<0.05). Rapamycin treatment reduced the left ventricular ejection fraction to 23.5% (P<0.05), and the collagen volume fraction of the ISO and ISO plus rapamycin groups was 5.9% and 25.9%, respectively, in TLR4 KO mice. Compared with the WT mice, Beclin1 and autophagy were downregulated in TLR4 KO mice (P<0.05); however, the ISO plus rapamycin group had higher autophagy activity than did the ISO group in TLR4 KO mice (P<0.05). Conclusions: Our results suggest that TLR4 knockout-induced cardioprotection against isoproterenol-induced cardiac fibrosis is associated with reduced autophagy induction. Cardiac fibroblast autophagy participates in its own activation. The moderate inhibition of autophagic activity may be a new strategy for treating cardiac fibrosis.
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Keratin and ankyrin repeat domain 1 protein identified by proteomic analysis may be involved in coronary artery disease Objectives: Circulating endothelial microparticles (EMPs) are recently suggested as a promising biomarker of endothelial function and target for cardiovascular disorders. However, increased studies reported that the biological effects of EMPs are ambivalent. The objective of this study is to identify proteins differentially expressed between patients with coronary artery disease (CAD) and control subjects. Methods: Different EMPs populations were generated from patients (n¼5) with CAD and control subjects (n¼5) for proteomic analysis by LC/MS. For the in vitro assessment, differential gene expression of identified proteins was validated by RT-PCR in HUVECs stimulated with TNF-a or ox-LDL. For further confirmation of candidate proteins in vivo, a total of 82 patients with CAD and 36 age-and sexmatched healthy controls were recruited. Detection of identified proteins in serum was carried out with ELISA. Results: By applying proteomic analysis, two proteins, namely, keratin and ankyrin repeat domain 1 protein (ANKRD1), were suggested as candidates. For further identification, exposure of HUVEC to TNF-a or ox-LDL up-regulated the expression of the mRNA levels of keratin and ANKRD1 in a concentration-dependent manner respectively (P<0.05). As for the in vivo experiment, keratin levels in the patients of acute coronary syndromes (ACS) and stable angina pectoris (SAP) groups were significantly higher than those of the control group (P<0.05), while ANKRD1 could distinguish patients with ACS from patients with SAP and control subjects, respectively. Conclusions: Increased levels of keratin and ankyrin repeat domain 1 protein are found in patients with CAD, rendering these two proteins as novel biomarkers and potential drug target for cardiovascular diseases. The specific molecular mechanisms require future studies.
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Uncoupling protein 2 knockout exacerbates salt-induced cardiovascular and renal remodeling Objectives: Cardiovascular and renal remodeling is the major determinant of progress of chronic cardiovascular and renal diseases. Our previous study demonstrated that uncoupling protein 2 (UCP2) plays a protective role in salt-induced vascular dysfunction via an antioxidative action. The aim of this study was to investigate the effects of UCP2 on salt-induced cardiovascular and renal remodeling. Methods: UCP2-knockout (KO) mice and wild-type (WT) littermates were fed with normal-salt diet (NS, 0.5%) and high-salt diet (HS, 8%) for 16 weeks. The histology, fibrosis, superoxide, expressions of matrix metalloproteinase (MMP) -2/-3/-9 and tissue inhibitor-1 of MMP (TIMP-1) in heart, aorta, mesenteric arterioles and kidneys were evaluated. Results: In WT mice, salt had little effect on cardiomyocyte size, but, in KO mice, salt caused a significant increase in cardiomyocyte size compared with NS group (217AE21 vs. 336AE23 mm 2 , P<0.01). As expected, salt-fed animals from both genotypes were found to have a significant fibrosis (both P<0.01). Interestingly, KO mice showed greater fibrosis after a salt intake compared with WT mice (20.8AE2.3% vs. 8.4AE1.6%, P<0.01). The wall thickness of both aorta and mesenteric arterioles were increased significantly due to salt-treated WT mice (both P<0.01) but were significantly higher in KO mice (aorta: 101AE7 vs. 82AE6 mm, P<0.05; mesenteric arterioles: 11.4AE1 vs 8.6AE0.8 mm, P<0.05). High-salt intake greatly increased aortic and mesenteric arteriolar fibrosis in both genotypes (both P<0.01), while had a significantly higher effect in KO mice (P<0.01 for aorta, P<0.05 for mesenteric arterioles). The high-salt diet resulted in no significant changes in glomerular and tubular size in WT mice, but a significant increase in KO mice (P<0.01 for tuft area, P<0.05 for tubular area). After 16 weeks of salt feeding, the glomerular tuft area in KO mice was significantly increased compared with WT mice (4.5AE0.5 vs. 2.8AE0.3 mm 2 , P<0.01). The salt administration caused a remarkably renal fibrosis in both genotypic mice (both P<0.01), while the salt-induced renal fibrosis was exacerbated KO mice compared with WT mice (34.2AE5.1 vs. 12.5AE2.2%, P<0.01). Fluorescence assay showed that salt-induced superoxide production in heart, aorta and kidney tissues were elevated in UCP2 KO mice compared with WT littermates (all P<0.01). The cardiovascular and renal remodeling in both genotypes was accompanied by increased MMP-2/-3/-9 and decreased TIMP-1 protein expression compared with control groups (all P<0.01). Conclusions: These data suggest that upregulation of UCP2 may attenuate the development of salt-induced cardiovascular and renal damage.
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Angiotensin II Type 2 Receptor Re-expression After the Collar-induced Adventitia Injury in the Rat Carotid Artery Objectives: The present study was undertaken to observe the effects of the chronic adventitia injury on angiotensin II type 2 Receptor (AT 2 R) expression in the rat carotid artery. Methods: Adventitia injury was induced by positioning a silicone collar around the right carotid artery for one week in 20 Wistar Kyoto rats. Both side of carotid was harvested for analysis of AT 2 R expression. The expression of AT 2 R mRNA and protein was assessed by RT-PCR and western bloting respectively. The expression distribution of AT 2 R protein was assessed by immunohistochemistry. Results: The AT 2 R mRNA expression increased 76% (P¼0.0061) and the AT 2 R protein expression increased 3.37 fold (P<0.0001) respectively in the collared right carotid artery when compared to non-collared left carotid artery. Immunohistochemical examination revealed that there was little AT 2 R expression anywhere in the noncollared left carotid artery and there was highly AT 2 R expression in intima and adventitia but not in media in the collared right carotid artery. Conclusions: The expression of AT 2 R mRNA and protein was upregulated in response to the collar placement. Collar-induced adventitia injury leaded to re-expression of AT 2 R in intima and adventitia of the rat carotid artery.
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b 2 adrenergic receptor selective agonist clenbuterol protects cardiac arrhythmia after reperfusion
Fu Qin Department of Pharmacology, Tongji Medical College, Huazhong University of Science and Technology
Objectives: Our Previous study has demonstrated that b 2 adrenergic receptor (b 2 AR) activation reduces infarct size and myocardial apoptosis after myocardial ischemia/ reperfusion. Cardiac arrhythmias are a major manifestation of reperfusion injury, which results in sudden death in acute myocardial infarction. The present study is designed to investigate whether b 2 AR agonist clenbuterol will protect cardiac arrhythmias induced by reperfusion. Methods: Reperfusion arrhythmias were induced by 10 min ligation of the left anterior descending coronary artery, followed by a 30 min reperfusion in anaesthetized rats. Electrocardiogram (ECG) in Lead II configuration was monitored throughout the I/R process. Cardiac damage was characterized by a higher incidence of reperfusioninduced ventricular tachycardia (VT) and ventricular fibrillation (VF).
Results: The incidence and severity of cardiac arrhythmias were significantly reduced by pretreatment with b 2 AR agonist clenbuterol in anesthetized rats. The protective effect of clenbuterol was attenuated by a selective b 2 AR antagonist ICI 118,551 or a gap-junction protein connexin (CX) inhibitor cabenoxolone. Clenbuterol also reduced the dephosphorylation and redistribution of Connexin 43 (CX43) induced by ischemia/reperfusion. Furthermore, pretreatment with clenbuterol significantly inhibited dephosphorylation of CX43 in isolated wild type not b 2 AR-knock out mouse hearts after ischemia/reperfusion injury.
Conclusions: These data demonstrated that b 2 AR agonist clenbuterol provides significant protection against arrhythmias induced by reperfusion, which is likely mediated at least in part by reducing dephosphorylation and redistribution of CX43, thereby enhancing the gating function of gap junctions in heart.
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Puerarin reduces inflammatory responses and apoptosis in LPS-stimulated cardiomyoblasts Yuan Yuan 1,2 , Qizhu Tang 1,2 1 Department of Cardiology, Renmin Hospital of Wuhan University, 2 Cardiovascular Research Institute of Wuhan University Objectives: To investigate the effect of puerarin, a kind of Chinese herbal medicine, on cardiomyoblast inflammatory response in a sepsis model using LPS. Methods: H9c2 cardiomyoblasts were incubated with different concentrations of puerarin (1mM, 5mM, 10mM, 20mM, 40mM) in the presence of LPS (1mg/mL) or not. The mRNA expression of inflammatory cytokine including IL-1, IL-6 and TNFa were detected using real-time PCR. Immunofluorescent staining was used to evaluate NFkB p65 nuclear translocation. LPS-induced apoptosis was measured by TUNEL staining and immunoblotting of Bcl-2 and Bax expression. The activation state of NFkB signaling was investigated using Western Blotting. Results: Puerarin blunted proinflammatory cytokine production in LPS-stimulated H9c2 cardiomyoblasts in a concentration dependent manner. In addition, treatment of H9c2 cardiomyoblasts with puerarin (40mM) inhibited LPS-induced apoptosis. Moreover, the NFkB p65 nuclear translocation and activation of NFkB signaling after LPS stimulation were suppressed by puerarin (40mM). Conclusions: Puerarin may serve as a valuable protective agent in cardiovascular inflammatory diseases.
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Exogenous Objectives: Coronary no reflow (NR) phenomenon of varying degrees widely exists in patients undergoing coronary artery recanalization therapy with type 2 diabetes mellitus (T2DM) significantly increasing the severity of it. Meanwhile, plasma adiponectin (APN) level is significantly reduced in patients with T2DM. To demonstrate whether hypoadiponectinemia could lead to aggravated coronary NR injury in T2DM and the protective effect of APN on coronary microcirculation, we conducted the following experiments. Methods: Healthy male SD rats of 6-week-old were fed with normal diet (10kcal %, ND) or high-fat and high-sugar diet (60kcal%, HD). All rats were fed continuously for 32 weeks. Body weight, fasting glucose, fasting insulin and serum APN levels were monitored regularly. 8 weeks later, intraperitoneal injections of glucose tolerance test (IPGTT) were performed every 4 weeks. And abnormal IPGTT was selected as a measurement for successful model of type 2 diabetes. Successfully fed type 2 diabetic rats and normal rats were divided into 4 groups: Sham group; normal control group (ND); diabetic rats group (DM); diabetic rats+globular adiponectin (gAd) intervention group (DM+gAd); gAd of 20mg/kg or 0.5ml of saline solution were injected into rats via tail vein at the 31st weekend. In each group, ischemia was produced via left anterior descending coronary artery slip-knot ligation for 1.5hours and then reperfusion for 12 hours. No reflow injury areas were measured using Evan's Blue and Thioflavin S staining methods. The reperfusion areas of myocardial microcirculation were showed with fluorescent microspheres. Left ventricular pressure was measured to evaluate cardiac function of rats. Serum adiponectin (APN), endothelin-1 (ET-1), intercellular adhesion molecule-1 (ICAM-1) and vascular endothelial adhesion molecule-1 (VCAM-1) levels were measured simultaneously to assess vascular endothelial injury. Results: (1) Serum adiponectin levels of diabetic rats increased firstly and then continued to reduce in the process of HD feeding. ET-1, ICAM-1, VCAM-1 in both DM group and DM+gAd group were significantly increased in the 32th weekend. After administration of gAd, ET-1 was significantly reduced (108.6.13AE8.428 vs.132.10AE7.213, P<0.05).
(2) NR injury in DM group was increased after I/R (48.64AE2.93% vs. 35.48AE4.31%, P< 0.05). Cardiac function showed obviously impaired (+dp/dt: 2514.36AE188.93 vs.3714.73AE118.90, P<0.01) with increased serum levels of ICAM-1 and VCAM-1.3) NR injury (28.48AE1.441% vs 48.64AE1.928%, P<0.01) and cardiac function after I/R injury in DM+gAd group improved significantly (+dp/dt: 3280.18AE192.84 vs.2514.36AE188.93, P<0.01) with decreased serum ICAM-1 and VCAM-1 levels.
